Columbia Care Announces Approval of Business Combination with Cresco Labs at Special Meeting of Shareholders
CANNANNEW REPORT

Overwhelming Columbia Care shareholder support with 98.5% of votes cast in favor of the business combination NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that at the special meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) held today, July 8, 2022, the proposed business combination with Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs”) was approved. The Shareholders voted in favor of a special resolution to approve the previously announced plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia) whereby, among other things, Cresco Labs will acquire all of the issued and outstanding shares of the Company, all as more particularly described in detail in the Company’s definitive proxy statement and information circular dated June 6, 2022 (the “Circular”) filed on SEDAR and with the United States Securities and Exchange Commission. Voting results are as follows:   FOR AGAINST ABSTAIN Percentage of shares(1) that were voted 98.55% 1.41% 0.04% (1) Assuming conversion of all proportionate voting shares into common shares. At the Meeting, a total of 169,938,646 Columbia Care Shares were represented in person or by proxy, representing 42.6% of the Columbia Care Shares issued and outstanding as of the close of business on May 10, 2022 (the “Record Date”) and entitled to vote at the Meeting as of the Record Date. “We are grateful for the overwhelming support of our shareholders as we move forward with the combination with Cresco Labs that will reshape the industry and redefine leadership in cannabis,” said Nicholas Vita, Co-Founder, CEO of Columbia Care. “As we celebrate this milestone, we remain steadfast in executing our strategic objectives through the close of the transaction,…

Excerpt only …
READ MORE BELOW
Source : Columbia Care Announces Approval of Business Combination with Cresco Labs at Special Meeting of Shareholders

reposted by Cannabis News World